Multiple sclerosis patients trial new drugs at Romford hospital
- Credit: Archant
Patients at Queen’s Hospital are at the cutting edge of developing new treatments for incurable neurological disease, multiple sclerosis.
David Downes, a council officer from Ilford, was diagnosed with the condition, known as MS, two years ago.
The married dad-of-two said it was a “relief” for him and his family to be given a diagnosis after months of uncertainty over what was making him ill.
Now he is one of three people testing a new drug which could help manage and improve symptoms.
The 47-year-old has been seeing a consultant at Queen’s, in Rom Valley Way, Romford, who suggested he take part in a clinical trial.
“He explained it would be good for me,” said David. “I carry on taking my normal medication as well, but I am monitored closely because I am also trialling a different drug.
“You build up a really personal relationship with the staff because you see them every week.
- 1 Homes under the Planner: Applications lodged or rejected in Havering
- 2 Fire crews free trapped driver after Hornchurch car crash
- 3 Woman 'slapped across face' in Brentwood restaurant
- 4 Romford accountant pleads guilty to 'calculated' £160k tax fraud
- 5 Plan for homes next to listed Hornchurch water tower rumoured to cover monks’ escape tunnel
- 6 Plans submitted for 35,000sqm of commercial floorspace in first phase of Rainham industrial estate redevelopment
- 7 Man dumps knife amid Hornchurch police chase
- 8 Confirmed: Rush Green Post Office set to move
- 9 Company dismisses 'unscrupulous individuals' reportedly caught flytipping in Rainham
- 10 Car park murder: Witness describes moment John Avers was run over
“If it also means I can help to develop drugs which could help other MS patients in the future then it’s a win-win situation.”
Three months into the year-long trial, David is already seeing improvements in his condition and recovery rates.
He is working closely with neurology research nurse Elisa Visentin who keeps a close eye on all patients taking part in medical trials.
She also has epilepsy and Parkinson’s disease patients trialling new treatments, and another observational study into MS.
She said: “I think that, because there is no cure for conditions like MS, there is a sense of altruism.”
“It’s a good club to be a member of,” said David. “I would have no hesitation in recommending other people to take part in trials.”
A spokesman for Barking, Havering and Redbridge University Hospitals NHS Trust, which runs Queen’s, said: “We have had great success in carrying out clinical trials – helping to investigate new medicines and treatments for a range of conditions.”